Description
Advanced Volumization and Facial Sculpting
Stylage XL is the most potent volumizing gel in the Stylage range, specifically formulated for patients suffering from significant facial volume loss (lipoatrophy) or those desiring a more defined facial structure. This high-viscosity monophasic HA gel is designed for deep dermis or subcutaneous injections, providing a structural scaffold that mimics natural bone and fat pads. By combining 26mg/ml of cross-linked HA with the protective properties of Mannitol, Stylage XL delivers immediate and dramatic results in facial remodeling.
Rheological Strength and Duration
The IPN-Like technology used in Stylage XL creates a dense, cohesive matrix that provides exceptional ‘G-Prime’. This means the filler has the mechanical strength to lift sagging skin and maintain its shape in high-movement areas of the face. The inclusion of Mannitol reduces the initial inflammatory response, which helps preserve the HA chains and extends the longevity of the treatment. Patients can expect the results of a Stylage XL treatment to last 12 to 18 months. The integrated lidocaine ensures that the deep placement required for this product is tolerable and stress-free for the patient.
Primary Uses: Cheeks, Chin, and Jawline
Stylage XL is the ideal choice for malar (cheek) augmentation, providing a youthful ‘lift’ that restores the triangle of beauty. It is also frequently used for chin projection and for sharpening the mandibular angle (jawline) to create a more contoured profile. Its high cohesion ensures that the filler stays precisely where it is placed, resisting migration. Because it is highly purified, the risk of granulomas or long-term complications is extremely low when administered correctly by a professional.
Professional Guidelines
As a professional-only medical device with CE certification, Stylage XL must be administered by qualified injectors. A deep understanding of the sub-dermal planes is essential to ensure safety and symmetry. Practitioners must avoid intravascular injection by performing aspiration tests and using appropriate cannula or needle sizes (typically 27G). Post-treatment care should include a 48-hour period without strenuous exercise. Proper storage is vital to ensure the product’s stability and the patient’s safety.
Reviews
There are no reviews yet.